135 related articles for article (PubMed ID: 37411025)
21. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
[TBL] [Abstract][Full Text] [Related]
22. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
23. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.
Smith JS; Backes DM; Hoots BE; Kurman RJ; Pimenta JM
Obstet Gynecol; 2009 Apr; 113(4):917-924. PubMed ID: 19305339
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review.
Skoulakis A; Fountas S; Mantzana-Peteinelli M; Pantelidi K; Petinaki E
BMC Infect Dis; 2019 Feb; 19(1):192. PubMed ID: 30808285
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.
Berger L; Wolf-Breitinger M; Weiß C; Tuschy B; Berlit S; Sütterlin M; Spaich S
Cancer Causes Control; 2023 May; 34(5):469-477. PubMed ID: 36854989
[TBL] [Abstract][Full Text] [Related]
27. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study.
Batman S; Messick CA; Milbourne A; Guo M; Munsell MF; Fokom-Domgue J; Salcedo M; Deshmukh A; Dahlstrom KR; Ogburn M; Price A; Fleming ND; Taylor J; Shafer A; Cobb L; Sigel K; Sturgis EM; Chiao EY; Schmeler KM
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2185-2191. PubMed ID: 36126275
[TBL] [Abstract][Full Text] [Related]
28. National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol.
Palmer M; Katanoda K; Saito E; Martellucci CA; Ostuki S; Nomura S; Ota E; Brotherton JML; Hocking J
Syst Rev; 2021 May; 10(1):135. PubMed ID: 33952342
[TBL] [Abstract][Full Text] [Related]
29. Safety, efficacy and immunogenicity of therapeutic vaccines in the treatment of patients with high-grade cervical intraepithelial neoplasia associated with human papillomavirus: a systematic review protocol.
Gonçalves CA; Lopes-Júnior LC; Nampo FK; Zilly A; Mayer PCM; Pereira-da-Silva G
BMJ Open; 2019 Jul; 9(7):e026975. PubMed ID: 31320349
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
31. Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review.
Nothacker J; Nury E; Roebl Mathieu M; Raatz H; Meerpohl JJ; Schmucker C
BMJ Sex Reprod Health; 2022 Oct; 48(4):295-306. PubMed ID: 36223918
[TBL] [Abstract][Full Text] [Related]
32. High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis.
Ezechi O; Akinsolu F; Salako A; Abodunrin O; Adewole I; Olagunju M; Okunbor H; Sanni-Adeniyi R; Zamba E; Njuguna DW; Eleje G
J Int Med Res; 2023 Jul; 51(7):3000605231182884. PubMed ID: 37409466
[TBL] [Abstract][Full Text] [Related]
33. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
34. The Risk Factors for Cervical Cytological Abnormalities Among Women Infected With Non-16/18 High-Risk Human Papillomavirus: Cross-sectional Study.
Xiao T; Ou CQ; Yang J; Wang C; Yang M; Yu T; Shen L; Xu X; Xing H
JMIR Public Health Surveill; 2022 Dec; 8(12):e38628. PubMed ID: 36480259
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the clinical efficacy of vaginal treatment options for persistent high-risk human papillomavirus infection after excisional treatment of cervical high-grade squamous intraepithelial lesions: a systematic review and Bayesian network meta-analysis.
Tang Y; Tong Q; Dai N; Xu C
Virol J; 2023 Mar; 20(1):47. PubMed ID: 36935507
[TBL] [Abstract][Full Text] [Related]
36. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
Huijsmans CJ; Geurts-Giele WR; Leeijen C; Hazenberg HL; van Beek J; de Wild C; van der Linden JC; van den Brule AJ
BMC Cancer; 2016 Nov; 16(1):922. PubMed ID: 27894291
[TBL] [Abstract][Full Text] [Related]
37. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
38. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
39. Gynecological concerns and vaginal practices and exposures among transfeminine individuals who have undergone vaginoplasty.
Hallarn J; Bauer GR; Potter E; Wilcox H; Newfeld J; Krakowsky Y; Ravel J; Prodger JL
J Sex Med; 2023 Oct; 20(11):1344-1352. PubMed ID: 37700562
[TBL] [Abstract][Full Text] [Related]
40. Cytology of the neovagina in transgender women and individuals with congenital or acquired absence of a natural vagina.
Grosse A; Grosse C; Lenggenhager D; Bode B; Camenisch U; Bode P
Cytopathology; 2017 Jun; 28(3):184-191. PubMed ID: 28217933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
